HB3041 HFLR Page 1
BOLD FACE denotes Committee Amendments. 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
HOUSE OF REPRESENTATIVES - FLOOR VERSION
STATE OF OKLAHOMA
2nd Session of the 59th Legislature (2024)
HOUSE BILL 3041 By: Stinson of the House
and
Stanley of the Senate
AS INTRODUCED
An Act relating to stem cell research; amending 63
O.S. 2021, Section 1-270.2, which relates to
permissible stem cell re search and reports to the
Governor and Legislature; adding an exception to the
filing requirement; and providing an effective date .
BE IT ENACTED BY THE PEOPLE OF T HE STATE OF OKLAHOMA:
SECTION 1. AMENDATORY 63 O.S. 2021, Section 1-270.2, is
amended to read as follows:
Section 1-270.2 A. For the purposes of the Advancement in Stem
Cell Cures and Therapies Act, "human embryo" means a living organism
of the species Homo sapiens at the earliest stage of development,
including the single-cell stage, that is not located in the body of
a woman.
B. Research on human tissue regeneration and human diseases
using adult stem cells and stem cells obtained from umbilical cord
HB3041 HFLR Page 2
BOLD FACE denotes Committee Amendments. 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
blood and amniotic fluid may be conducted in this state , provided
that the research is performed :
1. Safely and ethically;
2. Only on embryonic stem cell lines created prior to August 1,
2001, and in accordance with federal law as it exis ted on November
1, 2007; and
3. Without the use of a human embryo, inc luding a human embryo
produced using cloning technology.
C. When research is performed in accordance with the
Advancement in Stem Cell Cures and Therapies Act, a person or
governmental body shall not:
1. Restrict public funds designated for the stem cell research;
or
2. Obstruct or provide dis incentives for the stem cell
research.
D. The State Department of Health shall establish a reporting
system that collects information regarding all activities carried
out in accordance with this section.
E. The Department shall submit a report with all i nformation
collected pursuant to subsection D of this section to the Governor,
the Speaker of the Oklahoma House of Representatives, and the
President Pro Tempore of the Oklahoma State Senate no later than
December 31 of each year.
HB3041 HFLR Page 3
BOLD FACE denotes Committee Amendments. 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
F. Provided that there is no stem cell research to report that
year, the Department does not need to file a report.
SECTION 2. This act shall become e ffective November 1, 2024.
COMMITTEE REPORT BY: COMMITTEE ON PUBLIC HEALTH, dated 02/15/2024 -
DO PASS, As Coauthored.